Now available – Integrated Virtual ICANS Assessments Find out more.
Support clinical trials, post-approval monitoring, and real-world data generation with a solution designed to protect safety and reduce burdens on site teams.
Cell and gene therapies are accelerating from early trials to commercial delivery—and the boundaries between clinical research and clinical care are becoming harder to define.
To succeed, sponsors need more than software or site activation. They need a delivery partner with clinical-grade infrastructure, embedded at the point of care, and built to support the entire therapy lifecycle.
That’s where Current Health comes in.
We’ve partnered with leading cancer centers and pharmaceutical companies to move advanced therapies—including CAR-T and bispecifics—safely into outpatient and home settings.
With therapy-specific protocols, toxicity monitoring, and 24/7 clinical oversight, our model expands access without compromising safety or outcomes.
Enable decentralized or hybrid trials with remote monitoring, symptom tracking, and consistent data capture across sites.
Support REMS, ePRO collection, and regulatory-grade safety monitoring with scalable infrastructure already embedded in care delivery.
Equip provider partners with the tools, pathways, and real-time insights they need to deliver your therapy safely in the real world.
Generate high-integrity real-world evidence—from adherence to outcomes—across both trial and commercial programs.
Where infrastructure meets insight.
Our platform is already delivering results for some of the most complex therapies in oncology and immune disorders—across trials, post-market programs, and commercial delivery.
Earlier CRS detection than standard of care
Patients cared for through our solution
Avg alarm response time by our Clinical Command Center nurses
Patients successfully completed outpatient SUD with a bispecific antibody at MSK
Your clinical and operational infrastructure for better experiences.
Standardize workflows across trial sites or commercial programs for consistent data and patient experience.
Track vital signs and symptoms in near-real time through our FDA-cleared platform to detect safety signals and support protocol adherence.
Deliver pre-configured kits directly to patients, with remote onboarding and tech support included.
Structured, de-identified data can be synced directly into your EDC, RWD environment, or safety reporting systems—based on your protocol or evidence strategy.
Our Clinical Command Center is staffed 24/7 by nurses licensed in all 50 states to centralized triage and escalation, improving protocol adherence and supporting site teams.
Address CRS sooner with our comprehensive solution, which can detect signs of CRS 7 hours earlier than standard of care.
Integrated assessments and handwriting capture support detection of early signs of immune effector cell-associated neurotoxicity.
Capture patient-reported outcomes and symptoms digitally—mapped to your study design or label needs.
Streamline trial execution across geographies with a scalable platform for real-time monitoring, symptom tracking, and consistent data capture in high-acuity studies.
Enable hybrid or fully remote models without compromising oversight.
We can provide logistics, training, and support for academic and community sites.
Capture safety and symptom data ready for both analysis and future use.
Ensure consistency across geographies, regardless of care setting.
Expand therapy access with infrastructure that helps providers deliver your asset more efficiently, while giving you visibility into what happens post-prescription.
Equip providers with workflows, oversight, and logistics that support real-world use.
Make complex therapies more accessible with clinical-grade monitoring beyond the hospital.
De-risk rollout to new sites with end-to-end enablement services.
Gain real-time insight into adherence, experience, and therapy use.
Capture consistent real-world data across your patient base while ensuring safety, compliance, and insights that go beyond reporting checkboxes.
Monitor symptoms and side effects in real time across patient populations.
Support post-market requirements with standardized workflows and documentation.
Use structured RWD to support regulatory updates and extensions.
Capture ePROs and safety data suitable for reporting or internal analysis.
Generate the outcomes and economic evidence needed to support contracting conversations, payer confidence, and long-term access strategies.
Collect outcomes and resource use data aligned to evolving payer models.
Monitor adherence and therapy completion trends in community settings.
Generate structured data to support HEOR and cost-offset analyses.
Provide longitudinal insights across trials, label expansion, and real-world use.
We collaborate with our partners to contribute to the growing body of evidence for safe and effective outpatient advanced therapy delivery.
